Donell C.

Donell C. is a seasoned professional in clinical trial transparency and disclosure, currently serving as the Manager of Clinical Transparency at Regeneron since May 2022. Previously, Donell held the position of Clinical Trial Transparency and Disclosure Lead at bluebird bio, focusing on the implementation of transparency policies and managing vendor resources. Earlier roles include managing clinical trial results at Bristol Myers Squibb and serving as a Professor at Seminole State College of Florida and Valencia College, where curriculum development was a key responsibility. Donell's academic background includes a Ph.D. in Biochemistry from Washington University in St. Louis, complemented by Master's and Bachelor's degrees in Chemistry and Biology, respectively, from Florida A&M University. Over the years, Donell has demonstrated expertise in regulatory compliance, stakeholder communication, and research methodologies, contributing significantly to the field of clinical trial management.